Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep 23;85(13-14):517-25.
doi: 10.1016/j.lfs.2009.08.003. Epub 2009 Aug 15.

Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis

Yao-Jen Chang  1 , Jen-Wea Liu, Po-Cheng Lin, Li-Yi Sun, Chih-Wen Peng, Geng-Hong Luo, Tse-Min Chen, Ru-Ping Lee, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou
Affiliations

Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis

Yao-Jen Chang et al. Life Sci. .

Abstract

Aims: To investigate the feasibility and mechanism of liver damage repair using human bone marrow mesenchymal stem cells (hBMMSCs), we investigated the potential for hBMMSCs in recovery from liver damage, including fibrotic liver repair, using the CCl(4)-induced model for liver damage in the rat.

Main methods: Rats were injected with 0.5 ml/kg CCl(4) to induce liver damage and progressive liver fibrosis. hBMMSCs labeled with GFP were injected into the rats through the portal vein.

Key findings: After one day of transplantation, GFP-labeled cells were found around the liver lobules, the hepatic blood vessels, and the edge of the liver lobes. Biochemical and histopathological analyses showed significantly increased recovery from liver damage in the transplanted group. In addition, transplanted hBMMSCs express matrix metalloproteinases (MMP), and liver fibrosis was significantly decreased. The degree of fibrosis reduction paralleled the number of hBMMSCs observed in liver sections.

Significance: Our data suggest that hBMMSCs may facilitate recovery from chronic liver damage and may decrease liver fibrosis. Therefore, hBMMSCs are a potential option for treatment of liver cirrhosis.

PubMed Disclaimer